Published in Virology on April 01, 1993
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A (1996) 4.83
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol (1998) 3.84
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol (1995) 3.80
Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J Virol (1994) 3.48
Functional domains of the capsid protein of human immunodeficiency virus type 1. J Virol (1994) 3.47
Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol (1997) 3.28
Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A (2003) 3.20
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol (1998) 3.06
The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol (1995) 2.64
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol (1995) 2.56
Specificity and sequence requirements for interactions between various retroviral Gag proteins. J Virol (1994) 2.50
The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol (1997) 2.39
Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. J Virol (2000) 2.07
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J Virol (1994) 1.99
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J Virol (2002) 1.96
The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J Virol (1998) 1.91
Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). J Virol (2000) 1.90
Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol (1995) 1.73
A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. J Virol (2004) 1.68
Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. J Virol (2005) 1.55
Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents. J Virol (1996) 1.55
Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions. J Virol (1993) 1.52
Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging. Protein Sci (2005) 1.49
Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles. J Virol (1995) 1.44
Vif and the p55(Gag) polyprotein of human immunodeficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes. J Virol (1999) 1.44
Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J Virol (1998) 1.32
The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage. J Virol (2003) 1.25
Structural interactions between retroviral Gag proteins examined by cysteine cross-linking. J Virol (1995) 1.25
Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions. J Virol (1996) 1.16
Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting. J Virol (2000) 1.14
A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. J Virol (1995) 1.13
Tripeptide interference with human immunodeficiency virus type 1 morphogenesis. Antimicrob Agents Chemother (2002) 1.02
Effects of Gag mutation and processing on retroviral dimeric RNA maturation. J Virol (2006) 0.94
The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation. J Virol (2001) 0.92
The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes. Biophys J (2004) 0.79
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
Repair tracts in mismatched DNA heteroduplexes. Proc Natl Acad Sci U S A (1976) 5.88
The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci (1988) 5.00
Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi. Infect Immun (1993) 4.16
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol (1987) 4.12
Repair of defined single base-pair mismatches in Escherichia coli. Proc Natl Acad Sci U S A (1985) 3.88
Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84
Tom40 forms the hydrophilic channel of the mitochondrial import pore for preproteins [see comment]. Nature (1998) 3.77
Mismatch repair in Escherichia coli. Annu Rev Genet (1986) 3.71
Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol (2000) 3.70
Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine. Br J Cancer (2010) 3.25
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives;1979:71-79. Int J Epidemiol (2007) 3.13
A presequence- and voltage-sensitive channel of the mitochondrial preprotein translocase formed by Tim23. Nat Struct Biol (2001) 3.06
Identification of bacteria in a biodegraded wall painting by denaturing gradient gel electrophoresis of PCR-amplified gene fragments coding for 16S rRNA. Appl Environ Microbiol (1996) 2.95
A prokaryotic potassium ion channel with two predicted transmembrane segments from Streptomyces lividans. EMBO J (1995) 2.86
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Dose reduction in CT by anatomically adapted tube current modulation. I. Simulation studies. Med Phys (1999) 2.64
Predictors of automobile crashes and moving violations among elderly drivers. Ann Intern Med (1994) 2.63
Endocytosis in Chang liver cells. Quantitation by sucrose- 3 H uptake and inhibition by cytochalasin B. J Cell Biol (1971) 2.63
Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol (1998) 2.61
Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Microbiol Immunol (1998) 2.36
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Dose reduction in CT by anatomically adapted tube current modulation. II. Phantom measurements. Med Phys (1999) 2.29
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol (2013) 2.25
Cassini observes the active south pole of Enceladus. Science (2006) 2.15
Differential polymerase activity in avian and mammalian cells determines host range of influenza virus. J Virol (2007) 2.04
Reconstitution of a chloroplast protein import channel. EMBO J (1997) 2.03
Repair of a mismatch is influenced by the base composition of the surrounding nucleotide sequence. Genetics (1987) 2.03
Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience (1997) 2.00
E. coli ribosomes with a C912 to U base change in the 16S rRNA are streptomycin resistant. EMBO J (1986) 1.98
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A (1974) 1.97
Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins. J Virol (1999) 1.97
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet (2001) 1.94
T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein. J Immunol (1989) 1.94
Vir proteins stabilize VirB5 and mediate its association with the T pilus of Agrobacterium tumefaciens. J Bacteriol (1999) 1.93
Dose reduction in computed tomography by attenuation-based on-line modulation of tube current: evaluation of six anatomical regions. Eur Radiol (2000) 1.93
Involvement of Escherichia coli mismatch repair in DNA replication and recombination. Cold Spring Harb Symp Quant Biol (1984) 1.92
Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol (1998) 1.90
The two PAR leucine zipper proteins, TEF and DBP, display similar circadian and tissue-specific expression, but have different target promoter preferences. EMBO J (1996) 1.90
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued. Eur J Clin Pharmacol (1992) 1.86
Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses (1998) 1.83
E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs. J Virol (1998) 1.83
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol (2001) 1.81
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Virology (2000) 1.77
Mismatch repair of deaminated 5-methyl-cytosine. J Mol Biol (1987) 1.77
Persistence of Epstein-Barr virus in the parotid gland. J Virol (1984) 1.75
The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med (2001) 1.72
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill (2010) 1.69
Tim23 links the inner and outer mitochondrial membranes. Cell (2000) 1.68
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
PCR-based detection of mycobacteria in sputum samples using a simple and reliable DNA extraction protocol. Biotechniques (1994) 1.63
Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes. Eur J Biochem (1977) 1.63
High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol (1999) 1.60
Fetal and maternal diurnal rhythms during the third trimester of normal pregnancy: outcomes of computerized analysis of continuous twenty-four-hour fetal heart rate recordings. Am J Obstet Gynecol (1998) 1.60
Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proc Natl Acad Sci U S A (1980) 1.59
Use of Doppler ultrasound in performing percutaneous cannulation of the radial artery. Crit Care Med (1990) 1.59
Potential regulation of gene expression in photosynthetic cells by redox and energy state: approaches towards better understanding. Ann Bot (2008) 1.58
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect (2013) 1.58
The KEULE gene is involved in cytokinesis in Arabidopsis. Mol Gen Genet (1996) 1.58
Identification of proteins encoded by Epstein-Barr virus trans-activator genes. J Virol (1989) 1.58
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol (1995) 1.57
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides. Intensive Care Med (1993) 1.57
Tom22 is a multifunctional organizer of the mitochondrial preprotein translocase. Nature (1999) 1.56
Specific and sensitive two-step polymerase chain reaction assay for the detection of Salmonella species. Eur J Clin Microbiol Infect Dis (1996) 1.56
Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy (2004) 1.56
Purification and properties of Herpesvirus saimiri DNA. Virology (1974) 1.55
Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol (2000) 1.55
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci U S A (1997) 1.55
Tumor dedifferentiation: an important step in tumor invasion. Clin Exp Metastasis (1986) 1.54
Protein import channel of the outer mitochondrial membrane: a highly stable Tom40-Tom22 core structure differentially interacts with preproteins, small tom proteins, and import receptors. Mol Cell Biol (2001) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Dose reduction in CT by on-line tube current control: principles and validation on phantoms and cadavers. Eur Radiol (1999) 1.53
Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther (2000) 1.52
Origin of a chloroplast protein importer. Proc Natl Acad Sci U S A (1998) 1.51
Polymer-supported bilayer on a solid substrate. Biophys J (1992) 1.50
Exploring the open pore of the potassium channel from Streptomyces lividans. FEBS Lett (1999) 1.50
Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res (1997) 1.49
Methyl-directed repair of frameshift mutations in heteroduplex DNA. Proc Natl Acad Sci U S A (1986) 1.48
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
An integrated family of amino acid sequence analysis programs. Comput Appl Biosci (1988) 1.47
Effects of DNA methylation on mismatch repair, mutagenesis, and recombination in Escherichia coli. Curr Top Microbiol Immunol (1984) 1.47
Mutagenesis of the genes encoding subunits A, C, H, I, J and K of the plastid NAD(P)H-plastoquinone-oxidoreductase in tobacco by polyethylene glycol-mediated plastome transformation. Mol Gen Genet (1998) 1.47
Mismatch repair and recombination in E. coli. Cell (1987) 1.46